Earnings Call · Q3 FY2022·2022-11-12

Q3 22EPS +24.14%·Rev n/aQ2 22EPS -21.05%·Rev n/aQ1 22EPS +5.88%·Rev n/aQ4 21EPS -100.00%*·Rev n/a⚠ consensus missing

TREACE MEDICAL CONCEPTS, INC. TMCI

Vivian Cervantes — Investor Relations

John Treace — Chief Executive Officer

Mark Hair — Chief Financial Officer

−3.0%1d on move date−3.5% vs SPY3d+12.1%5d+14.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TMCI calls or request research access.

More TMCI calls Browse calls Request research access